Sign In
Buy HTBX
$2.38
+0 (+0%)
At Close: Aug 17, 2022
HTBX Stock Price Increases Over 6% Pre-Market: Why It Happened
09:19am, Tuesday, 26'th Jan 2021
The stock price of Heat Biologics Inc (NASDAQ: HTBX) has increased by over 6%. This is why it happened.
Heat Biologics: Investors Would Be Wise To Hold Off Until 2H 2021 Clinical Trial Interim Results
10:39pm, Sunday, 24'th Jan 2021
Heat Biologics: Investors Would Be Wise To Hold Off Until 2H 2021 Clinical Trial Interim Results
Heat Biologics Commences Manufacturing Process for ZVX-60
07:30am, Tuesday, 19'th Jan 2021
DURHAM, NC / ACCESSWIRE / January 19, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immu
Heat Biologics Promotes William L. Ostrander to Chief Financial Officer
08:00am, Monday, 11'th Jan 2021
DURHAM, NC / ACCESSWIRE / January 11, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the im
Heat Biologics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
04:00pm, Friday, 08'th Jan 2021
DURHAM, NC / ACCESSWIRE / January 8, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immun
Heat Biologics Reverse Stock Split: 10 Things for HTBX Stock Investors to Know
11:08am, Thursday, 10'th Dec 2020
Heat Biologics (HTBX) has announced details for a reverse stock split in order to keep shares of HTBX stock trading on the Nasdaq. The post Heat Biologics Reverse Stock Split: 10 Things for HTBX Stock
Heat Biologics Provides Update, And Other News: The Good, Bad And Ugly Of Biopharma
02:28am, Monday, 02'nd Nov 2020
Heat Biologics boosts patents portfolio with gp96 combination award. Teleflex announces acquisition of hemostatic company Z-Medica.
Foundation Medicine, Inc. and Takeda Pharmaceuticals USA, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK)
Janssen présentera les données essentielles de son vaste portefeuille d'oncologie au congrès virtuel de l'ESMO 2020
12:00am, Monday, 14'th Sep 2020
Les compagnies pharmaceutiques Janssen de Johnson & Johnson ont annoncé aujourd'hui que plusieurs présentations de données de leur portefeuille et
9 Reasons Why The Race For Major COVID-19 Vaccine Revenues Has Greatly Narrowed
10:06am, Wednesday, 02'nd Sep 2020
The huge amount of Operation Warp Speed funding for its six vaccines has helped them become somewhat dominant leaders in the race for a sizable share of the market.
Why Heat Biologics Stock Surged Today
05:54pm, Thursday, 13'th Aug 2020
Shares of Heat Biologics (NASDAQ: HTBX) popped on Thursday after the biopharmaceutical company shared promising preclinical data for its COVID-19 vaccine. As of 1:30 p.m. EDT, Heat Biologics' stock w
The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller
12:18pm, Thursday, 13'th Aug 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) * Annexon Inc (NASDAQ: ANNX) * Cellular Biomedicine Group Inc (NASDAQ: CBMG) (announced a go-private deal) * Fulgent Genetics Inc (N
Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies
11:00am, Thursday, 13'th Aug 2020
T cell driven immune response achieved with just a single dosePotential to be used in combination with other COVID-19 vaccine approachesDURHAM, NC / ACCESSWIRE / August 13, 2020 / Heat Biologics, Inc.
Why Novavax, Vaxart, Sorrento Therapeutics, and Other Coronavirus Stocks Plummeted Today
04:47pm, Wednesday, 12'th Aug 2020
Major new developments in the race for a COVID-19 vaccine are driving investors to reevaluate their positions.
Why Dynavax Technologies, Heat Biologics, and Inovio Pharmaceuticals Are Cratering Today | The Motley Fool
03:27pm, Tuesday, 11'th Aug 2020
Russia's surprise vaccine announcement isn't sitting well with shareholders of Dynavax, Heat Biologics, or Inovio Pharmaceuticals.
